We write regarding the administration of the Food and Drug Administration’s (FDA’s) Pediatric Rare Disease Priority Review Voucher (PRV) program, particularly the decision by the previous administration to deny a PRV for a one-time administered novel curative gene therapy that treats sickle cell disease.
Sen. Scott urges FDA to reconsider gene therapy decision.
Share
More from Tim Scott
American energy dominance requires more nuclear facilities and a modernized energy grid.
One spouse should not bear the responsibility for another spouse’s hidden income or mistakes, and the Tax Relief for Innocent Spouses Act gives the Tax Court greater authority to review the full scope of evidence in appeal cases.
With antisemitism on the rise and nations condemning Israel, the United States must remain clear-eyed, standing shoulder to shoulder with our Jewish brothers and sisters and our ally, Israel.
Keeping production at current levels would leave our country dependent on foreign energy sources, but by expanding nuclear energy here at home, America can power our future and pave our own way forward.
Other voices in this conversation
